Mode
Text Size
Log in / Sign up

Cardiology

939 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Furoscix (furosemide) for Edema in Heart Failure and CKD
Cardiology FDA Approval
FDA Approves Furoscix (furosemide) for Edema in Heart Failure and CKD FDA approves new diuretic Furoscix for heart and kidney patients
The FDA approved Furoscix (furosemide) subcutaneous injection for edema in pediatric patients weighing 43 kg and above and in adults with ch…
The FDA approved Furoscix (furosemide) to treat fluid buildup in adults and children weighing 43 kg or more with chronic heart failure or ki…
FDA Approves Ziac (bisoprolol/hydrochlorothiazide) for Hypertension
Cardiology FDA Approval
FDA Approves Ziac (bisoprolol/hydrochlorothiazide) for Hypertension FDA approves Ziac, a new combination pill for high blood pressure.
FDA approved Ziac (bisoprolol fumarate/hydrochlorothiazide) for the management of hypertension. The combination provides additive blood pres…
The FDA approved Ziac, a combination of two blood pressure medicines, for treating hypertension. It is for patients who need more than one d…
FDA Approves Avapro (irbesartan) for Hypertension and Diabetic Nephropathy
Cardiology FDA Approval
FDA Approves Avapro (irbesartan) for Hypertension and Diabetic Nephropathy FDA approves Avapro to treat high blood pressure and kidney disease in diabetes.
FDA approved Avapro (irbesartan) for hypertension and for diabetic nephropathy in hypertensive type 2 diabetes patients with elevated creati…
The FDA approved Avapro (irbesartan) for high blood pressure and for kidney disease in people with type 2 diabetes. It helps lower blood pre…
Behavioral and metabolic factors characterize a distinct premature atherosclerosis phenotype in Chinese patients
Cardiology Meta-analysis
Behavioral and metabolic factors characterize a distinct premature atherosclerosis phenotype in Chinese patients Smoking and Metabolic Factors Linked to Heart Attacks in China
This systematic review of 317 observational studies maps risk factors for premature myocardial infarction (PMI) in China. The synthesis iden…
A large review of 317 studies identifies specific behavioral and metabolic risk factors for heart attacks among Chinese patients.
Novel pharmacotherapies like resmetirom and GLP-1 receptor agonists offer potential concurrent hepatic and cardiovascular benefits
Cardiology Sys. Review
Novel pharmacotherapies like resmetirom and GLP-1 receptor agonists offer potential concurrent hepatic and cardiovascular benefits New Medications Show Potential to Treat Liver and Heart Disease
This systematic review examines the epidemiological links and shared pathophysiological mechanisms between metabolic dysfunction-associated …
Newer drugs like resmetirom and GLP-1 receptor agonists may offer dual benefits for patients with both liver and heart conditions.
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Cardiology Meta-analysis
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Antazoline May Beat Propafenone and Amiodarone for AF Conversion
Cardiology Meta-analysis
Antazoline May Beat Propafenone and Amiodarone for AF Conversion Antazoline shows better results for atrial fibrillation heart rhythms
A meta-analysis suggests antazoline is more effective than propafenone or amiodarone for converting atrial fibrillation to sinus rhythm, wit…
A new review suggests antazoline may be more effective than common medications at restoring normal heart rhythms for patients with atrial fi…
Ferroptosis regulation via phytochemicals and targeted delivery systems offers potential to mitigate doxorubicin-induced cardiotoxicity
Cardiology Sys. Review
Ferroptosis regulation via phytochemicals and targeted delivery systems offers potential to mitigate doxorubicin-induced cardiotoxicity New strategies may protect heart during chemo without reducing cancer fight
This systematic review examines the mechanisms of myocardial ferroptosis during doxorubicin treatment and evaluates various intervention str…
A review reveals innovative ways to shield the heart from doxorubicin damage while keeping its cancer-killing power intact.
Traditional Chinese medicine bioactive constituents may improve endothelial function and reduce oxidative stress in atherosclerosis
Cardiology Sys. Review
Traditional Chinese medicine bioactive constituents may improve endothelial function and reduce oxidative stress in atherosclerosis Traditional Chinese Medicine May Help Manage Atherosclerosis Symptoms
This systematic review synthesizes the mechanisms by which Traditional Chinese medicine (TCM) and its bioactive components influence atheros…
New research suggests that Traditional Chinese medicine and its components may help improve blood vessel health and reduce inflammation in a…
Percutaneous transcatheter closure using an Amplatzer Muscular VSD Occluder treats left ventricular pseudoaneurysm
Cardiology Guideline
Percutaneous transcatheter closure using an Amplatzer Muscular VSD Occluder treats left ventricular pseudoaneurysm Transcatheter Closure Shows Promise for Heart Failure Patients
This case report describes a 75-year-old male with heart failure and a left ventricular pseudoaneurysm successfully treated via percutaneous…
A new procedure using a transcatheter occluder may offer a safe way to treat heart failure caused by a specific heart wall defect.
Remote cardiac rehabilitation supported by mHealth improves exercise capacity in patients with heart failure
Cardiology Meta-analysis
Remote cardiac rehabilitation supported by mHealth improves exercise capacity in patients with heart failure Virtual cardiac rehab improves exercise capacity for heart failure patients
Researchers evaluated the impact of structured, remote, and hybrid cardiac rehabilitation programs compared to usual care or center-based mo…
Remote and hybrid heart rehabilitation programs using mobile health tools can improve walking distance and oxygen use in people with heart f…
Staged PCI reduces severe kidney injury risk after TAVR in aortic stenosis and CAD
Cardiology Meta-analysis
Staged PCI reduces severe kidney injury risk after TAVR in aortic stenosis and CAD Staged heart procedures may lower risk of severe kidney injury
This meta-analysis of 7,119 patients with aortic stenosis and coronary artery disease undergoing TAVR found that staged PCI did not signific…
A new look at heart surgery data suggests that spacing out certain procedures could protect kidneys from severe damage.